Revvity, Inc. (RVTY)

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.

Industry: Laboratory Analytical Instruments (SIC 3826)

Market region: US

Address: 77 4Th Avenue, Waltham, MA, 02451

Market capitalization

17.52 billion USD (17,519,064,957 USD)

Listing date

06/01/1972

Weighted shares outstanding

111,586,401

Share class shares outstanding

111,586,401

https://www.revvity.com